SML0922-25MG Display Image

NSC130813

Code: SML0922-25MG D2-231

Biochem/physiol Actions

NSC130813 blocks protein-protein interactions between XPF and ERCC1, two proteins involved in nucleotide excision repair (NER). The compound, NSC13081...


read more

Your Price
£391.00 25MG

Biochem/physiol Actions

NSC130813 blocks protein-protein interactions between XPF and ERCC1, two proteins involved in nucleotide excision repair (NER). The compound, NSC130813, blocks repair of DNA damage induced by platinum-based ctyotoxic drugs and DNA alkylating agents. NSC130813 synergistically potentiates cell death in cancer cell lines treated with cisplatin or mitomycin C.

Other Notes

air sensitive

Packaging

5, 25 mg in glass bottle

assay≥98% (HPLC)
coloryellow to orange
formpowder
Quality Level100
solubilityH2O: 10 mg/mL, clear
storage temp.−20°C
Code
Description
Unit Size
List Price
Qty
SML0922-5MG
Unit:5MG
List Price: £129.00
Source:List Price
ADD
Cas Number1082532-95-3
This product has met the following criteria: